MORFOLOŠKE KARAKTERISTIKE POSTELJICA S VILITISOM NEPOZNATE ETIOLOGIJE by Narloch, Charlotte
UNIVERSITY OF SPLIT 
SCHOOL OF MEDICINE 
 
 
 
 
Charlotte Narloch 
 
 
 
MORPHOLOGICAL CHARACTERISTICS OF PLACENTAS  
WITH VILLITIS OF UNKNOWN ETIOLOGY  
 
 
 
 
Diploma thesis 
 
 
 
 
Academic year: 
2017/2018 
 
 
Mentor: 
Sandra Zekić Tomaš, MD, PhD 
 
 
 
 
Split, July 2018 
UNIVERSITY OF SPLIT 
SCHOOL OF MEDICINE 
 
 
 
 
Charlotte Narloch 
 
 
 
MORPHOLOGICAL CHARACTERISTICS OF PLACENTAS  
WITH VILLITIS OF UNKNOWN ETIOLOGY  
 
 
 
 
Diploma thesis 
 
 
 
 
Academic year: 
2017/2018 
 
 
Mentor: 
Sandra Zekić Tomaš, MD, PhD 
 
 
 
 
Split, July 2018 
 TABLE OF CONTENTS  
 
1. INTRODUCTION ................................................................................................................ 1  
1.1. Development of Human Placenta: from the blastocyst until birth ......................... 2  
1.2. Villitis of Unknown Etiology (VUE) ..................................................................... 3  
1.3. Morphological characteristics of Placenta in various conditions ........................... 6  
1.3.1. Maternal Blood Flow Disturbances ........................................................ 6  
1.3.2. Maternal Vascular Malperfusion (MVM) ............................................... 9  
1.3.3. Fetal Blood Flow Disturbances ............................................................... 9  
1.3.4. Fetal Vascular Malperfusion (FVM) .................................................... 10  
1.3.5. Noncirculatory Lesions ......................................................................... 11  
2. OBJECTIVES ..................................................................................................................... 12  
3. MATERIALS AND METHODS ........................................................................................ 14  
4. RESULTS ........................................................................................................................... 16  
5. DISCUSSION ..................................................................................................................... 24  
6. CONCLUSIONS ................................................................................................................. 28  
7. REFERENCES ................................................................................................................... 30  
8. SUMMARY ........................................................................................................................ 33  
9. CROATIAN SUMMARY................................................................................................... 36  
10. CURRICULUM VITAE ................................................................................................... 38  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
ACKNOWLEDGMENT 
 
I am grateful for the chance to accomplish this diploma thesis thanks to my Sandra Zekić 
Tomaš, MD, PhD, who helped me and inspired me about the field of Pathology. 
 
I want to thank my family for the opportunity to study medicine especially my ‘Ziehvater’  
Dr. med. Jürgen Küchlin. 
 
Thank you, Pierre Sanchis, for your unconditional love. 
.
  1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. INTRODUCTION 
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1.1. Development of Human Placenta: from the blastocyst until birth 
 
The fusion of two gametes induces the development of fetus and placenta. After 
fertilization, the zygote gives rise to a newly formed blastocyst. The blastocyst is composed of 
an outer layer termed trophoblast, which are precursors of the placenta, and an inner cell mass 
termed embryoblast, forming embryo, umbilical cord and amnion (1).  
Six days after fertilization, implantation also termed nidation starts by blastocyst 
attachment with the embryonic side upfront on the endometrium. The implantation phase is 
characterised by progressive invasion of the blastocyst into maternal endometrium. The 
nidation process takes approximately three days and involves mainly the trophoblast cells, 
which differentiate into the outer syncytiotrophoblast (STB) or syncytium and the inner 
cytotrophoblast (CTB) layer (1,2). 
The multinucleated STB invades deeply the stroma of the endometrium. During this 
process two new cavities develop the yolk sac and the amnion. Those two cavities are separated 
by the embryonic disc, which will become the embryo. Following implantation, the whole 
endometrium attains the term decidua due to endometrial changes (1,2).  
The primary chorionic plate lies over the blastocyst cavity and forms later the fetal side. 
During the lacunar stage, the formation of vacuoles inside the STB takes place. These vacuoles 
fuse and give rise to lacunae. Trabeculae separate the lacunae and are the first villous 
extensions termed villous stems. Eventually the lacunae system fills with maternal blood and 
forms the intervillous space, which becomes the primary nutrient pool in between mother and 
child (1). 
Arising from the trabeculae, the trophoblastic shell (later replaced by the term basal 
plate) delimits the maternal side. The trophoblastic shell surrounds the whole embryo complex 
and is in contact with maternal decidua cells (1).  
The villous stages are characterised by the differentiation between primary, secondary 
and tertiary villi. As mentioned above, villi are formed by CTB migrating into trabeculae. Thus, 
primary villi consist of an inner layer of CTB and an outer layer of STB. Mesenchymal cells 
from the primary chorionic plate migrate towards the villi forming secondary villi. Fetal 
capillaries inside the villi characterise the tertiary villi. At the terminal portion of tertiary villi, 
trophoblastic cell columns form, attaching the villi to the trophoblastic shell and forming 
anchoring villi. Individual villi experience substantial branching inside the intervillous space 
(1).  
  
3 
Extravillous trophoblasts (EVTB), originating from CTB of the terminal portion of the 
villi, erode and transform spiral arteries inside the decidua. By this means, maternal blood 
empties into the intervillous space between fetal chorionic plate and maternal basal plate (1).  
The placenta consists of chorion frondosum, the fetal part, and decidua basalis, the 
maternal part. Chorion frondosum forms when villi on the placental site grow and extend. 
When the villi along the rest of chorion regress with time, this anatomical part is termed chorion 
laeve. The decidual basalis is the part of decidual cells lying over chorion frondosum. On the 
maternal side of placenta, decidual septa form and penetrate into intervillous space covered by 
syncytial cells. These septa form compartments termed cotyledons, visible on gross 
examination of maternal side (3). 
The formation of a primitive umbilical ring in a 5-week old embryo characterises the 
beginning of the umbilical cord development. It contains one connecting stalk; which includes 
umbilical vessels (two umbilical arteries and one umbilical vein) and allantois; the yolk stalk 
and a canal between intra- and extraembryonic cavities. The two stalks become enveloped by 
amnion and stuffed closely together forming the primitive umbilical cord. During the growth 
of the fetus, a physiological umbilical hernia forms due to a temporal small abdominal cavity. 
Next, the extra-embryonic cavity closes with repositioning of abdominal organs into fetus 
abdomen and additional regression of allantois and yolk stalk. The remaining umbilical arteries 
and vein become enclosed by Wharton’s jelly and complete the umbilical cord development 
(3). 
The continuous enlargement of uterus and growth of fetus leads to an increase in 
placental size. A full-term placenta usually accomplishes about 15-25 cm in diameter and 3 cm 
in thickness. It generally weights approximately 500-600g. The placenta is an important organ 
providing a place of exchange for oxygen, carbon dioxide, nutrients and waste in between 
mother and fetus. It plays also an immunologic role, transferring Immunoglobulin G 
transplacental to provide passive immunity for the fetus especially for the postnatal period. 
Additional endocrine function of the placenta provides human chorionic gonadotropin, 
progesterone, estrogenic hormones and somatomammotropin (2,3). 
 
1.2. Villitis of Unknown Etiology (VUE) 
 
VUE belongs to the group of chronic villitis, which can be divided into two groups 
regarding the etiology, either infectious or unknown. Chronic villitis is defined by a chronic 
inflammatory state of villi inside the placenta (1).  
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VUE presents commonly in 5-10% of all afterbirths usually affecting placentas of third 
trimester. The possible etiology of VUE supports strongly an underlying immune-mediated 
process rather than a potential infectious cause by a yet unknown or unidentified agent (1,4).  
The theory of an infectious cause is suggested due to similar histology of VUE 
compared to other known viruses causing chronic villitis. Infections often proceed without 
clinical symptoms and eventually are undetected without diagnosis (1).  
The following suggest an immune-mediated reaction as a cause of VUE: histiocyte 
infiltration on histology, its common reappearance, the inclination to run in families and the 
affected site of inflammation at the interface between mother and child (1).  It is believed that 
VUE resembles an allograft rejection and dominantly precipitated by infiltration of maternal T 
lymphocytes into fetal tissue. The maternal T lymphocytes, CD4+ and CD8+, are suggested to 
be present in VUE, as well as CD 68+ macrophages of maternal and fetal origin (5).  
All in all, VUE resembles a host-versus-graft reaction with fetal villous stroma 
destruction and resulting into interruption of maternal-fetal interface. It can be promoted by 
multiparity or ovum donation concerning in assisted reproductive technology or less relatable 
diseases as in diabetes or obesity (4). 
Placenta rigidity and smaller size on gross examination in VUE can be present. Mottling 
among necrotic villi appears in severe cases. All in all, there are no explicit changes 
determining VUE on gross examination (1).  
The diagnosis of VUE is determined by histological examination. Microscopically, 
inflammatory cells especially histiocytes and lymphocytes are identified. The inflammatory 
cell infiltration causes damage of villi vasculature, resulting into obliteration of blood flow (6). 
Associated destruction of villi due to necrosis causes the formation of avascular villi. The 
representation is either local or diffuse. The predominant involvement includes the villi of 
maternal basal plate (1). The inflammation location of affected villi in VUE can be 
differentiated in between maternal parabasal/paraseptal side, along in the midparenchyma, fetal 
subchorionic side or a combination of all (7).  
An important tool for VUE diagnosis is a grading schema (7). VUE is classified as low 
grade or high grade. Low grade VUE (Figure 1a) involves less than 10 villi per focus affected. 
According to an older grading scheme, low grade VUE can be further subclassified into focal, 
which includes less than 10 villi per focus on one microscopic slide, compared to multifocal, 
which can be demonstrated on multiple microscopic slides. On the other hand, high grade VUE 
(Figure 1b) is defined by the involvement of more than 10 villi per focus and can be 
subclassified according to an older grading schema into patchy, on multiple microscopic slides, 
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or diffuse, on all microscopic slides (8). Likewise, the Amsterdam Placental Workshop Group 
Consensus Statement published in 2016 a general grading model for VUE placentas, which 
included the classification of VUE into high grade and low grade without required further 
subclassification into focal, multifocal, patchy or diffuse (7).  
A single focus of infiltrated villi is rarely seen. In those cases the diagnosis is described 
as being ungradable with possible classification of low or high grade depending on the degree 
of affected villi described above (5,7). The differentiation between low grade VUE and high 
grade VUE is of utmost importance due to certain association in between high grade VUE and 
intrauterine growth restriction (IUGR), neurodevelopmental delay of fetus and high recurrence 
rate of high grade VUE in subsequent pregnancies (7). 
The impaired parts of the placenta, caused by VUE, undermine the nutrient and waste 
exchange between mother and child. Other events as prematurity, stillbirth or recurrent 
abortions can also present concomitantly with VUE (1).  
 
 
 
 
 
Figure 1a. Low grade villitis of unknown etiology (VUE), H&E, magnification 100X (Figure 
taken from Mentor’s archive). 
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Figure 1b. High grade villitis of unknown etiology (VUE), magnification 100X (Image taken 
from Mentor’s archive).  
 
 
 
1.3. Morphological characteristics of Placenta in various conditions 
 
Pathological abnormalities of the placenta can be divided into maternal blood flow 
abnormalities, fetal blood flow abnormalities and noncirculatory pathologies. Many of the 
following pathologies appear in healthy placentas and may have no clinical implication (6).  
 
1.3.1. Maternal Blood Flow Abnormalities  
  
These include perivillous and subchorionic fibrin deposition, subchorial thrombosis 
(Figure 2), retroplacental and marginal hematoma, and placental infarction (6).  
Firstly, Perivillous fibrin deposition can be found in a minority of investigated full-term 
placentas on gross examination but in nearly all placentas on histological examination. 
Presenting most commonly around the border of the placenta with solid, demarcated, 
discoloured yellowish or brownish white plaques. Histology shows on recent lesions, fibrin 
depositions followed by fibrosis surrounding the villi inside the intervillous space and finally 
vascular occlusion of affected villi. Older lesions present with disintegration of the outer 
placental membrane, the STB layer, surrounding the villi (6).  
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Figure 2. Massive subchorial thrombosis (Brues’ mole) (Image taken from Mentor’s archive). 
 
 
Secondly, subchorionic fibrin deposition, which presents on gross examination with 
solid, laminated, white plaques. On histology, laminated fibrin deposition spares the villi but 
infiltrate the chorionic plate. Subchorionic and perivillous fibrin deposition share the same 
pathogenesis of sudden maternal blood flow currents and stasis causing fibrosis in different 
anatomic locations (6).  
Subchorial thrombosis (Figure 2) presents on fetal surface with a protruding bulge 
composed of nodules and red thrombus on gross examination. Mainly fibrin and erythrocyte 
deposition can be found on histology. It can appear in some fatal pathologies as in abortion. 
Subchorial thrombosis should be distinguished from subamniotic hematoma, which affects a 
different anatomic zone lying more superficial and presents without thrombus formation on 
histology (6).  
Retroplacental hematoma presents usually with a crater-like depression and hematoma 
on maternal side of placenta. Recent hematomas appear soft, reddish and detach easily from 
specimen. Commonly the hematoma arrives already separated from the placenta inside the 
transport medium. Fibrin strands and polymorphonuclear cell deposition on histology can lead 
to recent retroplacental hematoma. However, older hematoma presents on gross examination 
brown and solid and on histology with infiltration of hemosiderin and macrophages. 
Additionally, a very fresh hematoma presents without any depression of placenta but with a 
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large portion of blood clot. Secondary infarction in retroplacental hematoma of the subjacent 
part of the placenta often occurs and if present could be seen on histology. The underlying 
pathological mechanism is based on diseased decidual blood supply, as it occurs in 
hypertension during pregnancy and detachment of placenta. The precise pathogenesis is not 
certain. A small retroplacental hematoma may not have any clinical significance due to 
placental blood reserve withstanding a villous surface loss of ≤30% (6).  
In comparison to marginal hematoma, which presents with a blood clot on the lateral 
margin of the placenta. It has no known clinical consequences on the placental function (6).  
Finally, placental infarction (Figure 3) occurs when maternal decidual arterioles 
become occluded most commonly by a thrombotic mass. It occurs in healthy term placentas 
involving less than 5% parenchyma but also in severe diseased placentas simultaneously 
affecting more parenchyma. Severe placental infarction is related to fetal hypoxia and even 
intrauterine fetal demise. A recent infarct is characterised by demarcated, dark reddish, hard 
lesions mostly at the periphery. An old infarct presents with harder, brown-yellowish or white 
lesions. On histology, infarcts differ in stages. Firstly, shrinkage of the intervillous space and 
packed villi can be found, followed by villous blood flow congestion and STB layer necrosis. 
Later on, nuclear shrinkage and fragmentation of STB and capillary collapse of affected villi 
with polymorphonuclear accumulation around the infarct are found. Finally, eosinophilic 
hyaline substance replaces syncytium with degeneration of stroma and capillaries. Old infarcts 
are marked by empty villi (6).  
 
 
Figure 3. Multiple chronic villi infarction of placenta (Image taken from Mentor’s archive). 
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1.3.2. Maternal Vascular Malperfusion (MVM) 
 
Recent literature proposed in 2016 a differentiation between maternal blood flow 
disturbances in placenta and maternal vascular malperfusion of placental bed (7). The 
following pathologies are part of MVM. Placental hypoplasia, is defined by placental weight 
below tenth centile and/or by the presence of a thin umbilical cord. On gross examination the 
placenta weights less than for the estimated gestational age appropriate (7).  
Two other pathologies belong additionally to MVM. Distal villous hypoplasia and 
accelerated villous maturation, part of abnormal villous development, are microscopic 
findings. Both findings can be found in placental insufficiency resulting into fetal growth 
restriction (FGR) and other pregnancy complications. In the end, many of the mentioned 
findings coexist in placentas (7).  
 
1.3.3. Fetal Blood Flow Disturbances 
 
The following pathologies are caused due to abnormalities of blood flow in fetus.  
Intervillous thrombosis presents with a size of 2-5 cm on gross examination with 
circular, soft and dark reddish lesions anywhere in the placenta, compared to older thrombi, 
which appear hard, whitish and stratificated. Additionally, thrombi of median age, present with 
a soft core and a firm outer zone. On histology fibrin lamellae with nucleated erythrocytes, 
which disappear with time, can be found. Intervillous thrombosis etiology is based on fetal 
capillary bleeding into the intervillous space due to STB rupture, resulting into mixture of 
maternal and fetal blood and thrombus formation. The incidence has no negative effect on 
placental action (6).  
Kline’s hemorrhage is a precursor of intervillous thrombosis and presents with nodular 
or bloody foci on gross examination (6).  
Another pathology of abnormal fetal blood supply is the fetal artery thrombosis 
characterised by a triangular pallor shape inside the placenta. The thrombosis cannot be shown 
on gross examination. The histology shows inside the pallor triangular form avascular villi with 
augmented stromal tissue. Additional STB knots can be found and the thrombosis of the fetal 
artery can be demonstrated on the tip of stem villi. Specialists should be aware of this pathology 
because of the possibility to miss those lesions. In rare cases when 40-50% of villi are affected 
the outcome can be intrauterine fetal demise (6).  
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As mentioned in the section of abnormal maternal blood supply of placenta, 
subamniotic hematoma describes a collection of blood between chorion and amnion and is 
usually caused by trauma during the delivery of fetus. Mostly, it does not affect the function of 
placenta but should be differentiated from subchorionic hematoma (6).  
 
1.3.4. Fetal Vascular Malperfusion (FVM) 
 
As mentioned above, the Amsterdam Placental Workshop Group Consensus Statement 
proposed a differentiation between fetal blood flow disturbances in placentas and fetal vascular 
malperfusion (7).  
The following pathologies are part of FVM: Umbilical cord lesions, segmental 
avascular villi, intramural fibrin deposition, villous stromal-vascular karyorrhexis and stem 
vessel obliteration (7).  
Umbilical cord lesions include hypertorsion of umbilical cord (Figure 4), presence of 
true knots and velamentous umbilical cord insertion. Avascular villi manifest due to a 
thrombosis of villi and downstream stem vessel obliteration visible on microscopic 
examination (7). 
 
 
 
Figure 4. Demonstration of pregnancy loss due to hypertorsion of umbilical cord (Image 
taken from Mentor’s archive). 
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Intramural fibrin deposition can affect the placenta globally with the possible result of 
placental insufficiency. Segmental fibrin deposition and its complication is yet unknown.  
Villous stromal-vascular karyorrhexis can also be termed hemorrhagic endovasculitis. In the 
end, stem vessel obliteration manifest with thickening of vessel wall and closure of vascular 
lumen on histological examination (7).  
 
1.3.5. Noncirculatory Lesions 
 
The noncirculatory lesions include calcifications of the placenta and chorionic cysts. 
Placental calcifications present along maternal placental side with widely distributed small 
whitish plaques with a hard rough-grained feel when sectioned.  
Chorionic cysts, which measure a size of 5-10 mm and contain a soft gelatinous 
substance on the inside with a membrane covered. They are located in the subchorionic area or 
among septa. Both lesions present with no known pathological consequences (6).  
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2. OBJECTIVES  
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The primary objective of this study is to compare placental morphological findings of 
placentas affected by VUE and healthy term placentas.  
The secondary objective of presented study is the comparison of morphological 
findings of placentas with high grade VUE with those from placentas with low grade VUE. 
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3. MATERIALS AND METHODS 
  
15 
Data collection has been withdrawn from the department of Pathology, Forensic and 
Cytology and department of Gynaecology and Obstetrics of University Hospital of Split. The 
study included 50 placentas diagnosed with VUE and 50 placentas from normal term 
pregnancies. All of the placentas included in the presented study were examined at the 
department of Pathology, Forensic and Cytology from the first of January 2016 until the first 
of April 2018.  
Inclusion criteria for placentas with VUE was the diagnosis of VUE based on 
histological examination of placental sample. The grading model for VUE placentas used in 
this study included the classification of VUE into high grade VUE and low grade VUE without 
required further subclassification into focal, multifocal, patchy or diffuse VUE. Low grade 
VUE involves less than 10 villi per focus affected and high grade VUE is defined by the 
involvement of more than 10 villi per focus (7). In case basal villitis was demonstrated, it was 
noted. The control group included placentas from term pregnancies without VUE diagnosis. 
The following data were obtained from the archive at department of Gynaecology and 
Obstetrics: birth weight, gender, gestational age and mother’s age. From the placental 
pathological reports, the following gross criteria were noted: the size of the placenta, including 
largest placental diameter and thickness, the umbilical cord insertion and umbilical cord length, 
hypertorsion of umbilical cord and true umbilical knots. The variations of umbilical cord 
insertion were noted on gross examination with following grouping: central insertion, 
paracentral insertion, paramarginal insertion, marginal insertion and velamentous insertion. 
Additionally, following pathohistological findings, if present, were included into the study: 
placental infarction, intervillous thrombosis, retroplacental hematoma, chorioamnionitis, 
funiculitis, deciduitis, fetal thrombotic vasculopathy, villous immaturity and accelerated 
villous maturation. Likewise noted lesions were furthermore grouped into MVM and FVM 
lesions and lesions due to maternal and fetal blood flow disturbances.  
Statistical analysis was done with the use of MedCalc software (MedCalc software, 
Mariakerke, Belgium) applying the chi-square-test, Student’s t-test and Mann-Whitney test, 
depending on the data distribution following Kolmogorov-Smirnov test. The statistical 
significance value was set at P˂0.05. 
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4. RESULTS 
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Our study included 100 placentas. The study group comprised 50 placentas with VUE 
diagnosis, while the control group included 50 term placentas without VUE diagnosis. In 30 
(60.0%) of the VUE placentas were diagnosed as low grade VUE, while remaining 20 (40.0%) 
placentas were characterized as high grade VUE. In 11 (22.0%) VUE placentas additional 
finding was villitis basalis, which was noted in 7 placentas with high grade VUE and 4 
placentas with low grade VUE.  
There was no statistically significant difference in the gender between two investigated 
placental groups (P=0.772; χ2=0.084; DF=1). The placentas with VUE had statistically 
significant lower gestational age than the control group (P<0.001; Z=5.209). The age of 
mothers in the VUE placenta group were higher than in the control group, which was a 
statistically significant finding (P=0.005; t=-2.889). Birth weight was statistically significant 
lower in the VUE group compared to the controls (P<0.001; t=6.044). IUGR was noted in 
42.9% of all cases in VUE group, while it was absent in the control group (Table 1).   
 
  
Table 1. Clinical information 
 Placentas with VUE 
(N=50) 
Control placentas 
(N=50) 
P 
Male gender (n(%)) 
 
22 (49.4) 27 (55.1) 0.772* 
Gestational age (weeks) 
 
36 (27-41) 39 (37-42) <0.001† 
 
Mother’s age (years) 
 
31±4.71 28±5.18 0.005‡ 
Birth weight (grams) 
 
2568±780 3364±491 <0.001‡ 
IUGRª 21 (42.9) 0 <0.001* 
Data are presented as mean±standard deviation, general number (%) or median with 
minimum to maximum values 
* chi-square test 
† Mann-Whitney test 
‡ Student’s t-test 
ª Intrauterine growth restriction 
 
  
18 
Table 2. Gross morphological findings  
 VUE group 
(N=50) 
Control group 
(N=50) 
P* 
Largest placental 
diameter (cm) 
 
17 (8-24) 18 (14-22) 0.073† 
Placental thickness 
(cm) 
 
2.5 (2-4) 3 (2-5) <0.001† 
UCª insertion 
Central 
 
Paracentral 
 
Paramarginal 
 
Marginal 
 
Velamentous 
  
 
4 (8.2) 
 
26 (53.1) 
 
9 (18.4) 
 
9 (18.4) 
 
1 (2) 
 
17 (14) 
 
18 (36) 
 
15 (20) 
 
6 (12) 
 
4 (8) 
 
 
 
0.187 
 
 
 
 
 
 
UCª length (cm) 
 
35.4±11 46.5±10 <0.001‡ 
Presence of UCª 
Hypertorsion  
 
15 (36.5) 12 (25) 0.539 
Presence of UCª true 
knot 
2 (4) 2 (4) 1 
 
Data are presented as mean±standard deviation, general number (%) or median with 
minimum to maximum values 
* chi-square test 
† Mann-Whitney test 
‡ Student’s t-test 
ª Umbilical Cord  
 
There was no statistically significant difference in the placental diameters (P=0.073; 
Z=1.790), however, placentas in VUE group were statistically significant thinner than 
placentas in the control group (P<0.001; Z=4.795) (Table 2).  
Paracentral umbilical cord insertion was the most common type of insertion in 
presented groups, there was no statistically significant difference in the type of umbilical cord 
insertion between VUE placentas and the control group (P=0.187; χ2=0.277; DF=4). Umbilical 
cord from VUE group were statistically significant shorter than umbilical cord from the control 
group (P<0.001; t=5.103). Hypertorsion of umbilical cord was noted in 15 placentas from VUE 
group and 12 placentas from the control group, this finding was not statistically significant 
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(P=0.539; χ2=0.376; DF=4). True umbilical cord knots were recorded in two placentas in the 
VUE group and two placentas in the control group (P=1; χ2=0.00; DF=1) (Table 2). 
 
  
Table 3. Pathohistological findings  
 VUE group 
(N=50) 
Control group 
(N=50) 
P* 
Accelerated villous 
maturation 
 
5 (10) 6 (12) 0.751 
Chorioamnionitis  
 
9 (18) 15 (30) 0.162 
Deciduitis 
 
1 (2) 1 (2) 1 
Fetal thrombotic 
vasculopathy 
 
5 (10) 0 0.023 
Funiculitis  8 (16) 0 0.003 
Intervillous 
thrombosis 
 
8 (16) 7 (14) 0.781 
Placental infarction 
 
9 (18) 6 (12) 0.403 
Retroplacental 
hematoma 
 
1 (2) 1 (2) 1 
Villous immaturity 3 (6) 5 (10) 0.463 
Data are presented as general number (%) 
* chi-square test 
 
Funiculitis was noted in 16.0% of VUE placentas and none of the placenta from the 
control group, likewise 10.0% of VUE placentas had fetal thrombotic vasculopathy that was 
not found among placentas from the control group. Both of the presented findings were 
statistically significant (P=0.003; χ2=8.609; DF=1 and P=0.023; χ2=5.211; DF=1) (Table 3). 
There was no statistically significant difference in the presence of placental infarction 
(P=0.403; χ2=0.699; DF=1), intervillous thrombosis (P=0.781; χ2=0.078; DF=1), 
retroplacental hematoma (P=1; χ2=0.00; DF=1),  chorioamnionitis (P=0.162; χ2=1.954; DF=1), 
deciduitis (P=1; χ2=0.00; DF=1), villous immaturity (P=0.463; χ2=0.538; DF=1) and 
accelerated villous maturation (P=0.751; χ2=0.101; DF=1) between both investigated groups 
(Table 3). 
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In 16 (32.0%) VUE placentas and 13 (26.0%) placentas from the control group signs of 
maternal vascular malperfusion were present and the difference was not statistically significant 
(P=0.433; χ2=0.511; DF=1).  
In 5 (10.0%) VUE placentas and none of placentas from the control group had signs of 
fetal vascular malperfusion, the finding was statistically significant (P=0.023; χ2=5.211; 
DF=1).  
Lesions due to maternal blood flow disturbances were noted in 11 (22.0%) of VUE 
placentas and 6 (12.0%) of placentas from the control group, the difference was not statistically 
significant (P=0.185; χ2=1.754; DF=1). 
Lesions due to fetal blood flow disturbances were noted in 12 (24.0%) of VUE 
placentas and 7 (14.0%) of placentas from the control group, the difference was not statistically 
significant (P=0.205; χ2=1.608; DF=1). 
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Table 4. Gross morphological findings in placentas with high grade VUE (HG VUE) and 
low grade VUE (LG VUE) 
 HG VUE group 
(N=20) 
LG VUE group 
(N=30) 
P* 
Largest placental 
diameter (cm) 
 
16 (8-24) 17 (15-23) 0.083‡ 
Placental thickness 
(cm) 
 
2.5 (2-3.5) 2.5 (2-4) 0.838† 
UC ª insertion 
Central 
 
Paracentral 
 
Paramarginal 
 
Marginal 
 
 Velamentous 
  
 
1 (5.3) 
 
10 (52.6) 
 
2 (10.5) 
 
6 (31.6) 
 
0 
 
3 (10) 
 
16 (53.3) 
 
7 (23.3) 
 
3 (10) 
 
1 (3.3) 
 
 
 
0.293 
 
 
 
 
 
 
UC ª length (cm) 
 
32.2±1.71 37.6±10.40 0.094‡ 
Presence of UC ª 
Hypertorsion  
 
7 (35) 8 (27.6) 0.584 
Presence of UC ª 
true knot 
0 2 (6.7) 0.243 
 
Data are presented as mean±standard deviation, as general number (%) or as median with 
minimum to maximum values 
*chi-square test 
‡ Student’s t-test 
† Mann-Whitney test 
ª Umbilical Cord  
 
There was no statistically significant difference in the placental diameters (P=0.083; 
t=1.773) or placental thickness between placentas with high grade VUE and low grade VUE 
(P=0.838; Z=0.204). The most common umbilical cord insertion site for both VUE placental 
groups was paracentral (P=0.293; χ2=4.942; DF=1). Although the umbilical cord length was 
longer in low grade VUE placentas, the finding was not statistically significant (P=0.094; 
t=1.712). Umbilical cord hypertorsion was noted in 7 high grade VUE placentas and 8 low 
grade VUE placentas, the finding was not statistically significant (P=0.584; χ2=0.300; DF=1). 
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In the low grade VUE group two placentas had true knots of the umbilical cord and none were 
present the high grade VUE placentas (P=0.243; χ2=1.361; DF=1). 
 
Table 5. Pathohistological findings in placentas with high grade VUE (HG VUE) and low 
grade VUE (LG VUE) 
 HG VUE (N=20) LG VUE (N=30) 
 
P* 
Accelerated villous 
maturation 
 
3 (15) 2 (6.7) 0.341 
Chorioamnionitis 
 
5 (25) 4 (13.3) 0.298 
Deciduitis 
 
0 1 (3.3) 0.414 
Fetal thrombotic 
vasculopathy 
 
1 (5) 4 (13.3) 0.341 
Funiculitis  3 (15) 5 (16.7) 0.876 
Intervillous 
thrombosis  
 
3 (15) 5 (16.7) 0.876 
Placental infarction 
 
5 (25) 4 (13.3) 0.298 
Retroplacental 
hematoma 
 
1 (5) 0 0.221 
Villous immaturity 2 (10) 1 (3.3) 0.336 
Data are presented as general number (%) 
*chi-square test 
 
There was no statistically significant difference in the presence of placental infarction 
(P=0.298; χ2=1.084; DF=1), intervillous thrombosis (P=0.876; χ2=0.024; DF=1), 
retroplacental hematoma (P=0.221; χ2=1.5; DF=1),  chorioamnionitis (P=0.298; χ2=1.084; 
DF=1), funiculitis (P=0.876; χ2=0.024; DF=1), deciduitis (P=0.414; χ2=0.667; DF=1), fetal 
thrombotic vasculopathy (P=0.341; χ2=0.907; DF=1), villous immaturity (P=0.336; χ2=0.927; 
DF=1) and accelerated villous maturation (P=0.341; χ2=0.907; DF=1) between investigated 
groups (Table 5). 
In 9 (45.0%) high grade VUE placentas compared to 7 (23.3%) low grade VUE 
placentas had signs of MVM, the difference was not statistically significant (P=0.111; 
χ2=2.537; DF=1).  
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FVM was noted in 1 (5.0%) high grade VUE placentas and 4 (13.3%) low grade VUE 
placentas, the difference was not statistically significant (P=0.341; χ2=0.907; DF=1). 
Lesions due to maternal blood flow disturbances were noted in 6 (30.0%) of high grade 
VUE placentas and 5 (16.7%) of placentas from low grade VUE group, the difference was not 
statistically significant (P=0.270; χ2=1.218; DF=1). 
Lesions due to fetal blood flow disturbances were noted in 4 (20.0%) of high grade 
VUE placentas and 8 (26.7%) of placentas from low grade VUE group, the difference was not 
statistically significant (P=0.592; χ2=0.287; DF=1). 
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5. DISCUSSION 
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VUE belongs to the group of chronic villitis in placenta and can be defined as 
infiltration of chorionic villi with chronic inflammatory cells (1). The diagnosis of VUE 
follows after pathohistological examination. Studies have shown that 80% of VUE cases 
mostly affect pregnancies after the 37th gestation week, while affected placentas before the 
22nd gestational week suggest a chronic villitis of an infectious etiology (9). If an infectious 
cause is excluded, the suggestive diagnosis is an idiopathic etiology, hence the name- villitis 
of unknown etiology. The majority believes that VUE is caused by an immune-mediated 
reaction (1).  
The results in this study show that placentas from older mothers are more often 
diagnosed with VUE placentas than from younger women. It is generally known that older 
women are more prone to various complications related to pregnancy, therefore one would 
expect a higher risk for VUE development in older women. Lower gestational age was noted 
in the VUE placental group compared to normal placentas. Although it is known that VUE is 
more common in term placentas (>37 weeks of gestation), results of this study suggest that 
median gestational age of VUE affected placentas is 36 weeks of gestation compared to 39 
weeks of gestation in the control group (1). From 21 newborn out of 50 within VUE placental 
group present with Intrauterine growth restriction (IUGR), not a single case was recorded in 
the control group. The findings of IUGR only in placentas from VUE group suggest IUGR as 
a single most common adverse pregnancy outcome in VUE affected pregnancies. The 
presented finding is in accordance with previously published studies, in fact some of the 
authors suggests that VUE is highly associated with Small for gestational age (SGA) babies 
and that VUE is an independent risk factor for the development of SGA (10). Presented result 
is valuable considering that IUGR is one of the most important adverse pregnancy outcomes 
(11). Additionally, Boog et al. mention in their study that 24-31% of all idiopathic IUGR cases 
could be caused by VUE (12).  
This study shows that placentas with VUE have shorter umbilical cord length than the 
control group and the most common umbilical cord insertion type was paracentral in both 
groups. From all mentioned umbilical cord insertion types, the velamentous type is pathologic 
and the rarest type. In the velamentous type the cord inserts into the membranes exposing the 
umbilical vessels without the protective Wharton’s jelly causing them to be prone to trauma 
and disruption (1). According to this study the umbilical cord insertion is most commonly 
paracentral in both studied groups, while the velamentous umbilical cord insertion is the least 
common umbilical cord insertion type. There is no suggestion that an association of VUE and 
type of umbilical cord insertion exist according to this study.  
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Our study showed that the umbilical cord length is decreased in our placentas with VUE 
compared to the normal term placentas, but still within the normal range, which is defined with 
a short umbilical cord length of <35 cm and a long cord of >70-80 cm. Umbilical cord length 
increases with gestational age as found in a Finnish retrospective study suggesting it (13). 
Likewise, the mentioned study found also that other variables as birth weight, maternal age, 
placental weight, pregravid maternal BMI and parity correlate with umbilical cord length (13). 
In general, literature explains that the entire umbilical cord is not submitted to the Pathology 
department. Short umbilical cord diagnosis should be considered with caution. Another 
unfortunate disadvantage is that the umbilical cord shrinks after the first few hours after 
delivery. Therefore, accurate recordings of umbilical cord length immediately after delivery is 
recommendable (1,14). 
Funiculitis and fetal thrombotic vasculopathy are statistically significant more frequent 
in placentas with VUE than in the control group. Acute funiculitis describes the inflammation 
of the umbilical cord and is part of an fetal inflammatory response following microbial 
ascending infection. Acute funiculitis typically presents with acute chorioamnionitis, which is 
a common pathology. Chronic chorioamnionitis, on the other hand, a recently described 
pathology, presents in 79% of cases with VUE. The presence of chronic chorioamnionitis 
should alert the pathologist to search for foci of chronic villitis (1). This study shows, not 
surprisingly, the presence of chorioamnionitis and placental infarction in both groups. Placental 
infarction is the most common and distinct MVM lesion on gross examination (1).  
On the other hand, fetal thrombotic vasculopathy is part of lesions due to FVM (1). The 
control group being unaffected by fetal thrombotic vasculopathy implicates that FVM are 
present in the pathogenesis of VUE. With regard to the location of VUE in more than half of 
cases the distal villi are affected. With a higher degree of VUE the stem villi are affected, and 
occasionally the chorionic plate. As a result, it causes thrombosis of stem villi vasculature and 
leads to fetal thrombotic vasculopathy (9).   
The second objective of this study includes the morphological characteristics of high 
grade VUE versus low grade VUE. There is no statistically significant difference regarding the 
gross morphological findings and pathohistological findings of low grade VUE compared to 
high grade VUE. A possible explanation could be the small sample size of comparison with 20 
high grade VUE placentas and 30 low grade VUE placentas. For further studies concerning the 
morphological differences in VUE grades, we recommend a larger sample size of placentas 
(15).  
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VUE is an important finding, especially high grade VUE due to its adverse impact on 
pregnancy outcome. Overweight females present often with recurrent high grade VUE and in 
those cases the complications of the fetus can range from mild neurological abnormalities to 
intrauterine fetal death. Other contributing factors to develop high grade VUE are diabetes, 
multiparity and in ovum donation according to Redline et al. (4). Those females carry a higher 
recurrence risk of VUE and those pregnancies should be considered as high-risk (9).  
The study contained a sample size of 100 placentas, 50 with diagnosed with VUE and 
50 healthy term placentas. One of the study limitation is the small sample size of placentas, 
especially among the investigated high grade VUE placentas and low grade VUE placentas. 
Another limitation to mention is the inability to include the mass of investigated placentas in 
this study. Unfortunately, it was impossible due to technical reasons encountered in the 
Pathology, Forensic and Cytology department.  
In the end, Boog et al. investigate treatment options with acetylsalicylic acid, 
immunosuppressants and Immunoglobulins in prevention of recurrent VUE in pregnant 
women. This research presents a clinical interest for further understanding of VUE (17).  
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6. CONCLUSIONS 
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1. This study shows on gross examination a thinner placenta and a shorter umbilical 
cord length in VUE placentas compared to the healthy term placentas. On pathohistological 
exam, the presence of funiculitis and fetal thrombotic vasculopathy was more frequent in VUE 
placentas than in the control group. From clinical point of view, the study implies that VUE is 
associated with IUGR. Likewise, a lower gestational age, older mother’s age and lower birth 
weight was found in placentas with VUE compared to healthy term placentas. 
2. There is no statistically significant difference found among investigated placental 
findings in the VUE group regarding VUE grading. We propose for the future further studies 
in high grade and low grade VUE with a larger sample size. 
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8. SUMMARY 
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Objectives: To investigate morphological characteristics of placentas with villitis of unknown 
etiology (VUE) and to compare them to normal term placentas without VUE, likewise, to 
compare placental morphological characteristics within the VUE group with regard to VUE 
grade.  
 
Materials and Methods: This study included 50 placentas diagnosed with VUE and 50 normal 
term placentas without VUE. Data collection and placental examination was carried out at the 
University Hospital of Split. VUE was diagnosed based on histological examination of the 
placentas and graded into low grade VUE and high grade VUE. Following lesions due to 
maternal and fetal blood flow disturbances and fetal and maternal vascular malperfusion were 
noted together with placental site, umbilical cord insertion and length. 
Statistical significance was tested using chi-square test, Student’s t-test and Mann-Whitney 
test. Statistical significance was proved by the P value ≤0.05.  
 
Results: From 100 placentas, there was a statistically significant result among clinical findings 
VUE placentas (n=50) and the control group (n=50) concerning gestational age (P<0.001; 
Z=5.209) and birth weight (P<0.001; t=6.044). In 42.9% placentas with VUE presented with 
IUGR (P<0.001; χ2=26.923; DF=1). Gross morphological findings manifested significantly a 
thinner placental thickness in cm (P<0.001; Z=4.795) and a shorter umbilical cord length in 
cm (P<0.001; t=5.103) in VUE placentas compared to healthy term placentas. 
Pathohistological findings manifested a statistically significant difference among funiculitis 
(P=0.003; χ2=8.609; DF=1) and fetal thrombotic vasculopathy (P=0.023; χ2=5.211; DF=1). 
Secondly, no statistically significant result differentiating morphological characteristics 
regarding gross and pathohistological findings in between high grade VUE (n=20) and low 
grade VUE (n=30) was found. 
 
Conclusions: On gross examination a thinner placental thickness and shorter umbilical cord 
length was found in placentas with VUE compared to healthy term placentas. On 
pathohistological exam funiculitis and fetal thrombotic vasculopathy implicate a finding of 
placentas in VUE. Secondly, there is no statistically significant result found among investigated 
placental findings in the VUE group regarding VUE grading. 
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9. CROATIAN SUMMARY 
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Naslov: MORFOLOŠKE KARAKTERISTIKE POSTELJICA S VILITISOM 
NEPOZNATE ETIOLOGIJE 
 
Ciljevi: Istražiti morfološke karateristike posteljica s vilitisom nepoznate etiologije (VUE) te 
dobivene rezultate usporediti s kontrolnom skupinom posteljica. Također, istražiti morfološke 
karakteristike u skupini VUE posteljica obzirom na histološki gradus vilitisa.   
 
Materijali i metode: 50 posteljica s VUE i 50 posteljica iz urednih terminskih trudnoća bez 
VUE dijagnoze je uključeno u istraživanje. Podatci su prikupljeni na Klinika za ženske bolesti 
i porode i Klinički zavod za patologiju, citologiju i sudsku medicinu KBC Split. Dijagnoza 
VUE u posteljicama je postavljena na temelju histološkog pregleda istih, te je VUE gradiran 
kao VUE niskog gradusa i VUE visokoga gradusa. Sve lezije nastale kao posljedica poremecaja 
cirkulacije majke i dijeteta te lezije koje su posljedica majčine vaskularne malperfuzije (MVM) 
i fetalne vaskularne malperfuzije (FVM) su zabilježene. Također su prikupljeni podatci o 
veličini posteljice, dužini i mjestu insercije pupčane vrpce kao i o majčinom i fetalnom 
upalnom odgovoru.  
 
Results: Niža gestacijska dob (P<0,001; Z=5,209), niža porođajna težina (P<0,001; t=6,044), 
te starija dob majke  (P=0,005; t=-2,889) su bili učestaliji u posteljicama s VUE nego u 
posteljicama kontrolne skupine.  42,9% novorođenčadi u VUE skupini je imalo intrauterini 
zastoj rasta (IUGR), dok u kontrolnoj skupini nijedno novorođenče nije imalo IUGR (P<0,001; 
χ2=26,923; DF=1). VUE posteljice su bile tanje (P<0,001; Z=4,795) i imale su kraću pupčanu 
vrpcu u usporedbi s posteljicama kontrolne skupine (P<0,001; t=5,103). Funikulitis (P=0,003; 
χ2=8,609; DF=1) i fetalna trombotična vaskulopatija (FTV) (P=0,023; χ2=5,211; DF=1) su bili 
učestaliji u VUE skupini nego u kontrolnoj skupini posteljica.  Nije bilo statistički značajne 
razlike u morfološkim karakteristikama u VUE skupini posteljica obzirom na histološki gradus 
VUE.  
 
Zaključak: VUE je učestao histološki nalaz posteljica trećeg tromjesečja. Naše istraživanje je 
pokazalo da posteljice s dijagnozom VUE imaju određene morfološke karakteristike kao i 
kliničke nalaze u smislu gestacijske dobi, porođajne težine te dobi majke koje su učestalije 
nego kod posteljica bez VUE. Kako bi se utvrdila točna povezanost navedenih razlika između 
VUE posteljica i posteljica kontrolne skupine potrebna su daljnja istraživanja.  
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